Skip to main content
Clinical Trials/ACTRN12620000739910
ACTRN12620000739910
Recruiting
未知

An evaluation of the clinical utility and acceptability of maternally-administered foetal heart rate monitoring using a remote medical device The HeraBEAT Trial.

Paul Porter0 sites120 target enrollmentJuly 16, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Pregnancy
Sponsor
Paul Porter
Enrollment
120
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 16, 2020
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Paul Porter

Eligibility Criteria

Inclusion Criteria

  • Any expectant mother over 18 years of age with a singleton pregnancy who is attending the Joondalup Health Campus antenatal clinic from 12 weeks gestation. Participants will be recruited as a convenience sample after eligibility is assessed.

Exclusion Criteria

  • 1\.Twin, triplets or other multi\-foetal pregnancies
  • 2\.Non\-English readers
  • 3\.Informed consent not obtained
  • 4\.No access to an appropriate smartphone or internet connectivity
  • 5\.Pacemaker or other implantable electronic devices
  • 6\.Skin condition or rash in the abdominal area
  • 7\.Anterior placenta
  • 8\.In active labour

Outcomes

Primary Outcomes

Not specified

Similar Trials